HI
KERX

HBK Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

HBK Investments’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-510,100
Closed -$1.8M – 1203
2015
Q3 		$1.8M Buy
+510,100
New +$3.42M 0.02% 439
2013
Q4 		– Sell
-62,300
Closed -$629K – 1066
2013
Q3 		$629K Buy
62,300
+51,300
+466% +$457K 0.01% 579
2013
Q2 		$82K Buy
+11,000
New +$86K ﹤0.01% 771

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

HBK Investments's KERX Position: Q4 2015 in Review

HBK Investments sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2015, closing a stake of 510,100 shares — an estimated $1.8M sold.

HBK Investments first reported a position in KERX in Q2 2013 and held it in 3 quarters. The position peaked at $1.8M in Q3 2015. 128 funds tracked by Wall St. Rank hold KERX as of Q4 2015.

  • HBK Investments reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • HBK Investments sold 510,100 Keryx Biopharmaceuticals Inc shares in Q4 2015, an estimated $1.8M.
  • HBK Investments first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 3 quarters.
  • HBK Investments's Keryx Biopharmaceuticals Inc position peaked at $1.8M in Q3 2015.
  • 128 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2015.

Based on HBK Investments's 13F filing for Q4 2015, filed 16 Feb 2016.